Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18Carcinoma, Hepatocellular 8Liver Neoplasms 7Colorectal Neoplasms 3Unresectable Pancreatic Cancer 2Stomach Neoplasms 2Neoplasm Metastasis 2Locally Advanced Pancreatic Cancer 2Cholangiocarcinoma 2Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pancreatic Adenocarcinoma Resectable 1Pancreatic Adenocarcinoma Locally Advanced 1Liver Metastasis Colon Cancer 1Liver Diseases 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colorectal Liver Metastases 1Bile Duct Neoplasms 1Advanced Gastric Cancer 1

Interventions

Bevacizumab 2regorafenib 1Radiofrequency Ablation 1PSMA-BCH 1Oxaliplatin 1IFL protocol 1FOLFOXIRI protocol 1Electroporation 1Cetuximab 1CPG-oligonucleotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Metastasis Colon Cancer × Electroporation × Gastrointestinal × Clear all
NCT06047015 2024-08-09

Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer

University of Saskatchewan

Phase 1/2 Not yet recruiting
12 enrolled
Gastrointestinal

Liver Metastasis Colon Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡